Patents by Inventor Katsuhide Miyake

Katsuhide Miyake has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240096307
    Abstract: A panel structure includes: a sheet-shaped core member having a thermoplastic property and provided with a plurality of protruding portions in at least one surface; a sheet-shaped faceplate having a thermoplastic property and disposed on the plurality of protruding portions; and a fusing portion which is selectively formed between the faceplate and the plurality of protruding portions and which bonds the core member and the faceplate to each other.
    Type: Application
    Filed: February 14, 2022
    Publication date: March 21, 2024
    Applicants: MITSUBISHI HEAVY INDUSTRIES, LTD., MITSUBISHI HEAVY INDUSTRIES MACHINERY SYSTEMS, LTD.
    Inventors: Takayuki Koyama, Kiyoka Takagi, Katsuya Sennyu, Yoshinao Takakuwa, Takayuki Miyake, Katsuhide Aikawa
  • Patent number: 7238100
    Abstract: The present invention provides a protein having a ?1,3-galactosyltransferase activity derived from a microorganism; a DNA encoding the protein; a recombinant DNA containing the DNA and a vector; a transformant obtained by introducing the recombinant DNA into a host cell; a method for producing a protein having a ?1,3-galactosyltransferase activity using the transformant; and a method for producing a galactose-containing carbohydrate using the transformant.
    Type: Grant
    Filed: June 14, 2004
    Date of Patent: July 3, 2007
    Assignee: Kyowa Hakko Kogyo Co., Ltd.
    Inventors: Katsuhide Miyake, Masaki Watanabe, Shinji Iijima
  • Publication number: 20050064559
    Abstract: The present invention provides a protein having a ?1,3-galactosyltransferase activity derived from a microorganism; a DNA encoding the protein; a recombinant DNA containing the DNA and a vector; a transformant obtained by introducing the recombinant DNA into a host cell; a method for producing a protein having a ?1,3-galactosyltransferase activity using the transformant; and a method for producing a galactose-containing carbohydrate using the transformant.
    Type: Application
    Filed: June 14, 2004
    Publication date: March 24, 2005
    Applicant: KYOWA HAKKO KOGYO CO., LTD.
    Inventors: Katsuhide Miyake, Masaki Watanabe, Shinji Iijima
  • Patent number: 6828128
    Abstract: The present invention provides a protein having a &bgr;1,3-galactosyltransferase activity derived from a microorganism; a DNA encoding the protein; a recombinant DNA containing the DNA and a vector; a transformant obtained by introducing the recombinant DNA into a host cell; a method for producing a protein having a &bgr;1,3-galactosyltransferase activity using the transformant; and a method for producing a galactose-containing carbohydrate using the transformant.
    Type: Grant
    Filed: July 9, 2001
    Date of Patent: December 7, 2004
    Assignee: Kyowa Hakko Kogyo Co., Ltd.
    Inventors: Katsuhide Miyake, Masaki Watanabe, Shinji Iijima
  • Publication number: 20020142425
    Abstract: The present invention provides a protein having a &bgr;1,3-galactosyltransferase activity derived from a microorganism; a DNA encoding the protein; a recombinant DNA containing the DNA and a vector; a transformant obtained by introducing the recombinant DNA into a host cell; a method for producing a protein having a &bgr;1,3-galactosyltransferase activity using the transformant; and a method for producing a galactose-containing carbohydrate using the transformant.
    Type: Application
    Filed: July 9, 2001
    Publication date: October 3, 2002
    Inventors: Katsuhide Miyake, Masaki Watanabe, Shinji Iijima
  • Patent number: 5939404
    Abstract: The present invention relates to the technology for inhibiting the cancer metastasis, and is aimed at the provision of a pharmaceutical composition for effectively inhibiting the metastasis of the cancer. A cancer metastasis inhibitor according to the present invention is characterized by containing a sugar chain separated from a surface of a Streptococcus agalactiae Ia type or Ib type as a main ingredient. Since the surface sugar chains of the Streptococcus agalactiae Ia type or Ib type have structures similar to surface sugar chains of the cancer cells, the former surface sugar chains adhere to E-selectin appearing in an intravascular endothelial cell, competitively inhibit the adhesion between intravascular endothelial cells and the cancer cells, and effectively prevent of the metastasis of the cancer, when the sugar chains exist in blood of a patient.
    Type: Grant
    Filed: August 19, 1997
    Date of Patent: August 17, 1999
    Assignee: NGK Insulators, Ltd.
    Inventors: Shinji Iijima, Katsuhide Miyake, Shin Yamamoto, Yasuko Yoshida, Mitsuo Kawase